takanashi satoshi

タカナシサトシ | takanashi satoshi

Affiliation and department：
Research theme for competitive and other funds (5)：

2022 - 2025 高齢発症関節リウマチ患者の臨床的・免疫学的特徴の解明と治療戦略の確立
2023 - 2024 difficult-to-treat rheumatoid arthritis (D2T RA: 難治性関節リウマチ)の病態解明と新規治療戦略の確立
高齢発症関節リウマチの病態解明と治療戦略の確立
高齢発症関節リウマチの病態解明と治療戦略の確立
ポストパラダイムシフト時代におけるDifficult-to-treat rheumatoid arthritis (D2T RA)の進展抑制を目的とした縦断的データ収集によるコホート研究

Papers (37)：

Koji Suzuki, Yasushi Kondo, Sho Ishigaki, Satoshi Takanashi, Yuko Kaneko. Clinical characteristics of cardiac involvement in idiopathic inflammatory myopathies: A retrospective cohort study. International journal of rheumatic diseases. 2024. 27. 7. e15273
Satoshi Takanashi, Tsutomu Takeuchi, Yuko Kaneko. Five-year follow-up of patients with difficult-to-treat rheumatoid arthritis. Rheumatology (oxford, england). 2024
Takashi Ishikawa, Kenichi Nishimura, Nami Okamoto, Keiji Akamine, Natsumi Inoue, Hitoshi Irabu, Kentaro Kato, Hiroshi Keino, Masayo Kojima, Hiroshi Kubo, et al. Efficacy and safety of tumor necrosis factor inhibitors for systemic juvenile idiopathic arthritis: a systematic review. Modern rheumatology. 2024
Kenichi Nishimura, Takashi Ishikawa, Nami Okamoto, Keiji Akamine, Natsumi Inoue, Hitoshi Irabu, Kentaro Kato, Hiroshi Keino, Masayo Kojima, Hiroshi Kubo, et al. Efficacy and safety of abatacept for systemic juvenile idiopathic arthritis: a systematic review. Modern rheumatology. 2024
Satoshi Takanashi, Yuko Kaneko, Yutaka Kawahito, Takashi Kida, Takahiko Sugihara, Toshihisa Kojima, Ryozo Harada, Michinori Ishitoku, Shintaro Hirata, Motomu Hashimoto, et al. A preliminary survey of rheumatologists on the management of late-onset rheumatoid arthritis in Japan. Internal medicine (tokyo, japan). 2024

ｍore...

MISC (33)：

高梨敏史, 金子祐子. 【10年間で登場した薬剤の市販後を総点検!病棟頻用薬の通信簿】(PART.3)承認後7年~10年(2014~2017) JAK阻害薬トファシチニブ,バリシチニブ. 薬事. 2024. 66. 6. 1221-1225
高梨敏史, 金子祐子, 白井悠一郎, 桑名正隆, 陶山恭博, 石黒賢志, 杉原毅彦, 南木敏宏, 中西研輔, 金城光代, et al. 内科医のための臨床問題集症例問題膠原病(12問)Question30~41. Medicina. 2024. 61. 4
高梨敏史, 金子祐子. Peficitinib. 臨床リウマチ. 2023. 35. 3. 153-161
高梨敏史. Effectiveness and safety of tocilizumab for polymyalgia rheumatica (PMR). 月刊リウマチ科. 2023. 69. 5. 595-601
Yoshida Tsuneyasu, Onishi Akira, Hasegawa Yasuhiro, Yanai Ryo, Takanashi Satoshi, Fukui Sho, Watanabe Shinji, Hirahara Lisa, Morinobu Akio. Biologics JAK-1 整形外科手術における周術期のヤヌスキナーゼ阻害薬休薬が手術部位感染と関節リウマチ再発に及ぼす影響多施設観察研究(The effect of perioperative Janus kinase inhibitor withdrawal on surgical site infection and relapse of rheumatoid arthritis in orthopedic surgery: a multi-center observational study). 日本リウマチ学会総会・学術集会プログラム・抄録集. 2023. 67回. 386-386

ｍore...

Education (2)：

Awards (6)：

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page